Technology Opportunities

BGN (13)
BioRap (5)
Carmel (11)
Mor (5)
Technion (16)
Tel Hashomer (10)
Refine / Revise Search60 technologies found
page 1 of 3
A Method and System for Detecting P-Waves in the surface Ecg Signal (BGN)
Scientific Contact: Yaniv Zigel
More Details...
A New Biomarker for early Prostate Cancer detection (BioRap)
Prostate cancer (CaP), an adenocarcinoma of the prostate, is the most common cancer in American males over the age of 55 and the second cause of cancer-related mortality. The current diagnosis of prostate cancer is based on the measurements of serum prostate-specific antigen (PSA) levels. ...
More Details...
A New Kit for Prediction and Prevention of Diabetes-Related Complications (BioRap)
A test method based on a genetic polymorphism in the Haptoglobin gene identifies those individuals with Diabetes who are at high risk for developing heart, eye and kidney disease and who benefit from specific drug treatments, has been validated in multiple clinical trials worldwide. Diabetes is ...
More Details...
A Novel Diagnostic Kit for early detection of Hypercoagulation (BioRap)
A kit which greatly shortens time and improves accuracy required to diagnose blood coagulation problems, and improves the design of personalized treatment regimen, is being developed by Prof. Brenner and Dr. Aharon and clinically tested and the Rambam Medical center Hypercoagulation is a term ...
More Details...
A Process for Creating a Three – Dimensional Configuration on a Substrate (BGN)
Scientific Contact: Robert Marks
More Details...
Advancing Treatment for Schizophrenia (Carmel)
Researcher : Dr. Inna Gaisler-Salomon Background Schizophrenia is a severe mental disorder that is characterized by debilitating symptoms of impaired perception, cognition, speech, affect and behavior. According to the National Institute of Mental Health (NIMH), the prevalence of schizophrenia is ...
More Details...
Assay for Detecting Circulating Free Necleic Acids (BGN)
Scientific Contact: Amos Douvdevani
More Details...
Automatic decision support system for contrast enhanced spectral mammography (Tel Hashomer)
Automatic decision support system for contrast enhanced spectral mammography Dr. Miri Scalier and Dr. Arnaldo Mayer Categories Medical Imaging, Breast Cancer , Mammography, Woman Health Development Stage Prototype for clinical studies , ongoing clinical studies Patent Status ...
More Details...
BLOOD BRAIN BARRIER DISRUPTING AGENTS AND USES THEREOF (Tel Hashomer)
Yael Mardor, Itzik Cooper, David Last, David Guez, Yoram Shechter and Mati Fridkin Sheba Medical Center and the Weizmann Institute of Science, Israel Background Most therapeutic agents are BBB impermeable. Their arrival from blood to brain i.e. to suppress brain tumors is currently an ...
More Details...
Cancer multidrug resistance diagnostic method for personalize chemotherapy (Technion)
The present technology provides a quick and reliable test to identify multidrug resistance in cancer cells and personalize chemotherapeutic drug treatment. ...
More Details...
Cannabinoids (Cannabis): Treatment and prevention of neuropsychiatric disorders (Carmel)
Researcher: Prof. Irit Akirav Revealing the therapeutic potential of cannabinoids for the prevention and treatment of post-traumatic stress disorder (PTSD), depression and other stress-related disorders. BackgroundAccording to a 2001 World Health Organization report, 450 million people around the ...
More Details...
Cells containing a nanopatch sensor in their membrane (BGN)
Scientific Contact: Jelinek Raz
More Details...
Clinical support tool- Interstitial Fluid Velocity Assessment of Solid Tumors from MRI (Tel Hashomer)
Clinical support tool- Interstitial Fluid Velocity Assessment of Solid Tumors from MRI Maya Dadiani, Arnaldo Mayer & Miri Sklair-Levy, Sheba Medical Center, Israel Categories Medical imaging, Image analysis, Cancer Treatment Evaluation Development Stage First ...
More Details...
Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof (Technion)
A method of selecting a semaphorin for treating cancer in a subject is disclosed. The method comprises determining an expression of a semaphorin receptor on tumor cells of a tumor sample of the subject wherein an ...
More Details...
Defeating Dementia: Drug Development for Cognitive Enhancement (Carmel)
Researcher: Prof. Edi Barkai Discovering a new drug treatment approach to inhibit the onset of dementia. Background : Dementia, most commonly Alzheimer’s disease, is a devastating chronic brain condition that disrupts thinking, orientation, behavior, and memory processes. Individuals ...
More Details...
Detector Comprising a Membrane Perturbation –Detecting Polymer and Functional Membrane Fragments (BGN)
Scientific Contact: Jelinek Raz
More Details...
Diagnostic Kit for the Identification of Human Infection with Urogenital Mycoplasmas (Mor)
Background Mycoplasmas are a group of bacteria characterized by unique features - they are the smallest replicating, free-living bacteria. Comprising a minimal genome and lacking a cell wall, properties making difficulties in research and diagnosis. Mycoplasmas are very common inhabitants of ...
Scientific Contact: Shulamith Horowitz
More Details...
Diagnostics for early detection of ovarian cancer (Tel Hashomer)
Diagnostics for early detection of ovarian cancer Keren Levanon and Tamar Geiger, Sheba Medical Center and Tel Aviv University, Israel Categories Diagnosis, Ovarian Cancer, Development Stage Proof of concept, Efficacy Studies Patent Status Pending THM Reference ...
More Details...
Dispersion-controlled adjustment of imaging plane in spectrally encoded endoscopy (Technion)
The spectrally encoded endoscopy (SEE) is a new method utilizing a single optical fiber and miniature diffractive optics to encode transverse reflection from a sample. The use of this method dictates the geometry of the focal plane which limits in many applications where the object is in a ...
More Details...
Dr. Monica Dines & Dr. Rafi Lamprecht: MCI Program: Development of A Drug for the Treatment of Fear and Anxiety Related Disorders (Carmel)
Dr. Rafi Lamprecht Project Name: Drug development for PTSD patients Principal researcher name: Dr. Monica Dines & Dr. Rafi LamprechtInvention area: Pharma Background: The formation and storage of fear memory is needed to adapt behavior and avoid danger during subsequent fearful events. However, ...
More Details...
ITTN's partners are affiliated with some of the world's leading Educational and Research Institutions.